Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53

Ogawara, Yoko, Kishishita, Shohei, Obata, Toshiyuki, Isazawa, Yuko, Suzuki, Toshiaki, Tanaka, Keiji, Masuyama, Norihisa, Gotoh, Yukiko·2002·Journal of Biological Chemistry
DOI 10.1074/jbc.m109745200

Cited by (617)

Items 601–617 of 617

  1. Identification de marqueurs membranaires spécifiques de cellules progénitrices cardiaques PW1+ par une approche multiomique
    Olivier Claude · 2018 · theses.fr (ABES)
  2. Characterization of Pten and Trp53 deficient prostatic tumors in mice
    Rana El Bizri · 2018 · theses.fr (ABES)
  3. Les rôles tubulaires et macrophagiques de la périostine dans les maladies rénales aigues
    Raphaël Kormann · 2018
  4. Rôle de l'histone désacétylase HDAC6 au cours de l'érythropoïèse humaine
    Pascal Vong · 2022 · theses.fr (ABES)
  5. Mechanistic insights into the combined use of cisplatin and propranolol in cervical cancer implications for overcoming drug resistance
    Fateme Rezvani Dehaghani, Mahfam Soleimanzadeh, Elham Rajabbeigi, Leila Mohaghegh Shalmani, Fatemeh Javani Jouni, Jaber Zafari · 2026 · Advances in Cancer Biology - Metastasis
  6. Plasminogen Activation System and Fibroblasts: Impact on Tissue Remodeling, Disease, and Organ Homeostasis
    Fathimath Muneesa Moideen, Yashodhar P. Bhandary · 2026 · Inflammation
  7. Comparing the Relationship between Dietary Glycemic Index and Load with Aging Gene Expression in Visceral Adipose Tissue of Normal Weight adults and adults with obesity
    A Kazemdarashti, G Eslamian, Azam Shakery, Hamid Zand, Niki Tadayon, H Ardehali, Sepideh Fazeli Taherian · 2026 · Iranian Journal of Nutrition Sciences and Food Technology
  8. Computational approaches to pleiotropic drug design for intestinal ischemia-reperfusion injury
    Oluwaseun Samuel Hezekiah, Oladele Ayobami Afolabi, Richard Adedamola Ajike, Olubunmi Simeon Oyekunle, Ezekiel Oladele OJO, Abigail Iyanuoluwa KOMOLAFE · 2026 · In Silico Research in Biomedicine
  9. Muricadienin analogs as potent triggers of mitochondrial apoptosis and replicative stress in P53-deficient Cancer cells: A structure-activity relationship study
    Regina A. Tuktarova, Pavel Konkin, Usein Memetovich Dzhemilev, Georgii V. D'yakonov, Lilya Useinovna Dzhemileva, Vladimir Anatol'evich D'yakonov · 2026 · Bioorganic Chemistry
  10. Anti-cancer effects of plant extracts in head and neck squamous cell carcinoma
    Haoran Zhou, Yafei Li, Lu Liu, Bo Li · 2026 · Frontiers in Pharmacology
  11. MYC–SNHG7–miR-34a-5p Feedback Loop Orchestrates GSDMD-Dependent Pyroptosis in Hepatocellular Carcinoma
    Houemakou Rimaud Djidonou, Laís de Carvalho Gonçalves, Djorkaeff O. Fontinele, Daner A. Silveira, Marialva Sinigaglia, João Paulo Matos Santos Lima, José C. M. Mombach, Shantanu Gupta · 2026 · International Journal of Molecular Sciences
  12. Nucleic acid therapeutics for reinvigorating p53 function in glioblastoma: concepts, limitations and recent advances
    Alexander Hagstotz, Susanne Michen, Achim Aigner, Ilker Y. Eyüpoglu, Achim Temme · 2026 · Pharmacology & Therapeutics
  13. BindingDB Entry 50021256: Advancements in dual-target inhibitors of PI3K for tumor therapy: Clinical progress, development strategies, prospects.
    BindingDB · 2025 · UC San Diego
  14. An investigation of EPO as a tissue protective agent in human kidney transplantation
    D.G. de Freitas · 2011 · OpenGrey (Institut de l'Information Scientifique et Technique)
  15. Cellular resistance to DNA Topoisomerase I-targeting drugs
    Kae Yanase, Toshiwo Andoh · 2003 · Springer eBooks
  16. Doctorate Program in Molecular Oncology and Endocrinology
    Josefina Martinez Hoyos · 2006
  17. Inhibition of AKT Oncogenic Pathway in Endometrial Cancer Cells
    Jiayuh Lin, Xiaohong Jin, Dana R. Gossett, Shaomeng Wang · 2003 · Springer eBooks